Cerity Partners LLC Bio N Tech Se Transaction History

Cerity Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $68,788 - $88,056	-856 Reduced 17.75%	3,967 $318,000
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $429,054 - $541,864	4,823 New	4,823 $444,000
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $8,825 - $11,064	72 Added 0.35%	20,648 $2.57 Million
Q4 2022 Feb 15, 2023	BUY	$118.43 - $186.05 $2.44 Million - $3.83 Million	20,576 New	20,576 $3.09 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.